There are at least two different etio-pathogenic pathways for the development of vulvar squamous cell carcinoma (VSCC): one associated with infection by human papillomavirus (HPV) and another independent of HPV. We aimed to describe the histological characteristics of HPV-associated and -independent tumors and to determine the best strategy to identify HPV in VSCC. A single paraffin block was available for review from a series of 1,594 VSCCs. In all cases HPV DNA detection was analyzed using the SPF10PCR/DEIA/LiPA25 system and p16 immunohistochemistry (IHC). A tumor was considered as unquestionably HPV-associated if both HPV DNA and p16 IHC were positive. A tumor was considered indisputably HPV-independent if both HPV DNA and p16 IHC were negative. Two groups of tumors were classified as non-conclusive: (1) HPV DNA1/p162 and (2) HPV DNA2/p161. WHO typing and a thorough histological evaluation were conducted in all cases. Four hundred and fortyone tumors were HPV DNA1 with 367 cases (23.0%) being HPV DNA1/p161. The latter tumors were more frequently basaloid or warty (49.8%), but 36.5% were of the keratinizing type; 1,153 tumors were HPV DNA2, with 1,060 cases (66.5%) being HPV DNA2/p162. These HPV DNA2/p162 tumors were mostly keratinizing (81.2%) but were occasionally basaloid or warty (5.2%). The features of HPV DNA2/p161 cases (n 5 93) were similar to those of the HPV-associated VSCC, and HPV DNA1/ p162 (n 5 74) cases had a more diverse profile, although they were more similar to HPV-independent tumors. Several histological characteristics were more frequently associated with HPV-related VSCC (koilocytotic-like change, necrosis, moderate to marked pleomorphism, invasive front in nests; p < 0.001), however, none of these characteristics allowed differentiation between HPV-associated and -independent VSCC. In conclusion, histological criteria do not allow differentiation between HPVassociated and -independent VSCC. p16 Alone is a clinically easy strategy to determine HPV status in VSCC.
Introduction
Vulvar squamous cell carcinoma (VSCC) accounts for <5% of the gynecological malignancies but represents >90% of the malignant tumors of the vulva. 1 VSCCs can be subdivided into human papillomavirus (HPV)-associated and HPV-independent tumors, with HPV-associated tumors representing one-fifth to one-half of all VSCC. [2] [3] [4] [5] Increasing evidence indicates that these two different types of VSCC not only have different epidemiological, clinical, pathological and molecular characteristics, but also a different clinical behavior. These differences stress the need of considering HPV-associated and -independent vulvar tumors as two separate entities. [6] [7] [8] Most pathologists use clinico-pathological criteria to classify vulvar tumors as HPV-associated or -independent. The current WHO classification 9 recognizes several histological variants of VSCC, including the basaloid, warty, keratinizing and nonkeratinizing subtypes. HPV-associated tumors are considered to have a warty or basaloid histology, [10] [11] [12] [13] and affect younger women. [14] [15] [16] [17] [18] [19] Contrarily, HPV-independent lesions generally have a keratinizing morphology and occur in elderly women. 14, [20] [21] [22] [23] [24] However, a number of studies indicate that these pathological features have a limited usefulness to determine HPV status. 14, [20] [21] [22] Moreover, a comprehensive study analyzing histological characteristics of HPV-positive and -negative carcinomas has yet to be conducted.
Recent studies have shown that HPV DNA alone may be insufficient to identify HPV-associated cancers outside the cervix. [25] [26] [27] [28] In recent years very sensitive and specific mRNA RT-PCR assays have been developed, 28 but these tests are extremely technically complex, and consequently are not adequate for pathology laboratories in routine daily practice. p16 Immunohistochemistry (IHC) has shown to be a useful tool to classify VSCC into HPV-associated or -independent and is considered a good surrogate marker of HPV-association in the vulva and in other anatomical sites in which HPV-associated and -independent tumors are present. 2, 14, 16, 22, [28] [29] [30] [31] [32] However, many studies evaluating p16 IHC have included a limited number of cases and, consequently, the reliability of p16 positivity as a single marker of HPV-association is not known. Recently, the combination of two markers has been proposed as a reliable tool to provide robust results in terms of HPV status. 2, 28 In this strategy, tumors positive for HPV DNA and p16 would be indisputably HPV-associated, whereas tumors negative for the two biomarkers would be classified as unquestionably HPV-independent. However, it is not known whether the tumors with intermediate features (HPV DNA positive and p16 negative and HPV DNA negative and p16 positive) truly represent HPV-associated or -independent tumors. In our study, we analyzed a large series of 1,594 tumors conducting a thorough histological analysis and detection of HPV using HPV DNA, p16 IHC and HPV mRNA. The study had three main goals: (1) to describe the histological characteristics of indisputably HPV-associated (HPV DNA1/p161) and HPVindependent tumors (HPV DNA2/p162); (2) to determine the frequency and the features of the tumors with non-conclusive features (HPV DNA2/p161 and HPV DNA1/p162) and (3) to determine the best strategy to differentiate HPV-associated and -independent tumors.
Material and Methods

Study design and materials
We reviewed all the invasive vulvar carcinomas previously analyzed in a retrospective cross-sectional survey coordinated by the Catalan Institute of Oncology (ICO, Barcelona, Spain) in collaboration with DDL Diagnostic Laboratory (Rijswijk, the Netherlands). 2, 33 In the present analysis we included all the cases fulfilling the following inclusion criteria: (1) invasive squamous carcinoma identified in the block; and (2) Today, most pathologists use clinico-pathological criteria to classify vulvar tumors as human papillomavirus (HPV)-associated or HPVindependent. However, a comprehensive study analyzing histological characteristics of HPV-positive and -negative carcinomas has yet to be conducted. Here, the authors set to describe the histological characteristics of HPV-associated and -independent tumors and determine the best strategy to identify HPV-associated tumors in a large series of 1,594 vulvar cancers. They show that histological criteria do not allow differentiation between HPV-associated and HPV-independent neoplasms, and that p16 immunohistochemistry alone is an easy clinical strategy to determine HPV status in vulvar cancer.
percentage of cells showing koilocytotic-like change, individual keratinization, and differentiated features (large, eosinophilic cytoplasm), percentage of tumor showing necrosis, extent of the inflammatory infiltrate adjacent to the tumor and severity of the pleomorphism (these latter characteristics were semi-quantitatively evaluated as absent, mild, moderate or severe). The invasive front of the tumors was classified as having a nested (large or small nests) and diffuse pattern. Nested invasion consisted of either large geographic nests with frequent central comedo-type necrosis or small nests with frequent central keratin pearls. 34 A diffuse (or infiltrative) front was defined by irregular cords or single atypical cells in a so-called spray pattern, often with surrounding desmoplastic stroma. Pattern evaluations were performed at low-power (34 to 310) magnification. Figure 1 shows the main histological features evaluated in all the tumors.
Immunohistochemical staining for p16 and p53
All tumors were stained with p16 monoclonal antibody using the CINtec Histology Kit (clone E6H4; Roche-Mtm-Laboratories, Heidelberg, Germany). 35 Only cases showing positivity in >25% of tumor cells with strong and diffuse block staining of the basal layer were considered as positive (p16 INK4a upregulation). 28, 36 p53 Immunohistochemistry was performed in the first 192 cases of the whole series of 1,594 tumors. p53 was detected with the monoclonal anti-body DO-7 (Dako, Carpinteria, CA). p53 was considered positive when >25% of the neoplastic cells exhibited nuclear staining.
Tissue preparation, nucleic-acid isolation and HPV DNA detection DNA extraction was performed on whole sections of the FFPE tissue from the surgical specimen or from pre-treatment biopsy. The samples were serially sectioned on a microtome. The first and last sections (3 lm) were stained with H&E for histological confirmation of the diagnosis. In-between sections were collected in RNAase-free reaction tubes for DNA isolation (sandwich cutting technique). Sectioning and sample preparation were carried out with the highest measures to avoid crosscontamination. Paraffin blocks lacking tissue were cut inbetween the patient samples as controls to ensure the lack of contamination. Processing and pathology diagnosis were done by the reference laboratory.
DNA extraction and HPV DNA detection have been previously described. 37 Briefly, HPV DNA detection was done using SPF10 PCR, DEIA and the LiPA25 system (version 1, Laboratory Biomedical Products, Rijswijk, the Netherlands). 
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HPV mRNA detection
The mRNA extraction and mRNA detection from tissue ribbons were performed as previously described. 28 For each case, HPV type-specific E6*I mRNA RT-PCR assays were performed for the HPV type(s) previously determined by genotyping and for a cellular ubiquitin C gene as a control for tissue quality. HPV E6*I mRNA assays were developed for the following HPV types: 16, 18, 26, 31, 33, 35, 39, 45 , 51, 52, 53, 56, 58, 59, 66, 67, 68, 70, 73 and 82. A second assay was performed to assess the presence of HPV16 E6*I mRNA in all cases, irrespective of the HPV DNA result. Cases with HPV mRNA positive (HPV mRNA1) and/or ubiquitin C mRNA1 signal were considered "RNA valid." All "RNA invalid" samples [i.e., cases that were HPV mRNA negative (HPV mRNA2) and ubiquitin C mRNA2] were analyzed a second time, and according to the signals obtained, they were classified as "RNA valid" or "RNA invalid." HPV E6*I mRNA was analyzed in all the HPV DNApositive cases and in a subset of 18 randomly selected HPV DNA-negative cases as a negative control. A total of 18 HPV DNA2 cases were tested (10 HPV DNA2/p162 and 8 HPV DNA2/p161 cases).
Classification of tumors as HPV-associated andindependent. Tumors with non-conclusive features
A tumor was considered as unquestionably HPV-associated if both HPV DNA and p16 IHC were positive. A tumor was considered indisputably HPV-independent if both HPV DNA detection and p16 IHC were negative. These cases were considered the gold standard for HPV-positivity and -negativity, respectively. Two groups of tumors were classified as nonconclusive for HPV association: (1) tumors testing negative for HPV DNA but with positive staining for p16 (HPV DNA2/p161); and (2) tumors testing positive for HPV DNA, but with negative result for p16 (HPV DNA1/p162).
Statistical analysis
The results were reported as means, absolute frequencies and percentages. v 2 analysis or Fisher's exact test was used for comparisons between nominal variables. Data were analyzed with the program SPSS (version 15.0; SPSS, Inc., Chicago, IL). All statistical tests were two-sided, and a p-values of 0.05 or less was considered statistically significant.
Results
HPV DNA, p16, p53 and histological typing: HPV-associated, -independent tumors and tumors with non-conclusive features Four hundred and forty-one tumors (27.7%) were positive for HPV DNA, and 1,153 (72.3%) were negative. Three hundred and sixty-seven out of 441 HPV DNApositive tumors (83.2%) were positive for p16 IHC; however, 1,060 out of 1,153 HPV DNA-negative tumors (91.9%) were negative for p16 IHC. The percentage of tumors of basaloid or warty type slightly increased in HPV-associated tumors (49.8%), whereas the percentage of histologically keratinizing tumors slightly increased in HPV-independent tumors (81.2%). Figure 2 shows an example of unquestionably HPVassociated VSCC with keratinizing histology (HPV DNA1/ p161), and two indisputably HPV-independent VSCC (HPV DNA2/p162) with basaloid and warty characteristics.
One hundred and sixty-seven tumors (10.5%) showed a nonconclusive profile. Ninety-three tumors were HPV DNA2/ p161; and 74 tumors were HPV DNA1/p162. Table 2 shows the WHO classification and age distribution of the indisputably HPV-associated tumors (HPV DNA1/p161), the unquestionably HPV-independent tumors (HPV DNA2/p162 tumors) and the tumors with non-conclusive profiles. The tumors with a HPV DNA2/p161 profile were similar to the indisputably HPV-associated tumors in terms of WHO typing (p > 0.05). The HPV DNA1/p162 tumors had indeterminate features, although they were more similar to the unquestionably HPV-independent tumors (slightly higher proportion of wartybasaloid tumors in the HPV DNA1/p162 group compared to HPV DNA2/p162 group; p < 0.001).
There were marked differences between these two groups in terms of age (61.7 6 16.7 in the indisputably HPVassociated tumors vs. 71.7 6 13.4, in the unquestionably HPV-independent tumors; p < 0.001). Interestingly, the mean age of the patients with tumors with a HPV DNA2/p161 profile was similar to that of the women with indisputably HPV-associated tumors (p > 0.05). Contrarily, the HPV DNA1/p162 cases were similar in age distribution to the HPV-independent tumors. From the subset of 192 tumors stained for p53, a positive result was observed in 2 out of 40 (5%) unquestionably HPV-associated tumors (HPV DNA1/p161 profile) and in 88 out of 140 (62.9%) unquestionably HPV-independent tumors (HPV DNA2/p162 profile). In the group of HPV DNA2/p161 tumors, p53 was negative in all six tumors tested (0/6; 0%), whereas in the group of HPV DNA1/p162 tumors, 4/6 (66.7%) were positive for p53. Table 3 shows the histological characteristics of the indisputably HPV-associated tumors and the unquestionably HPVindependent tumors, as well as the characteristics of the HPV DNA-positive and -negative tumors without p16 IHC. Several histological characteristics were more frequently associated with HPV-associated tumors (koilocytotic-like change, necrosis, moderate to marked pleomorphism, invasive front in nests; p < 0.001), whereas individual keratinization, keratin pearls, highly differentiated cells and a diffuse invasive front were more frequently associated with HPV-independent VSCC (p < 0.001). However, none of the histological features allowed reliable differentiation between the two types of VSCC as all of the characteristics were present in a proportion of both types of tumors. Table 4 shows the results of the HPV typing and the histological classification of the tumors according to the typing in the 441 cases positive for HPV DNA and in the group of 367 unquestionably HPV-associated tumors. HPV16 was, by far, the type most frequently identified. p16 IHC was positive in over 90% of cases positive for HPV16 and 45, in over 80% of the cases positive for HPV18 and 33, in over 70% of multiple HPV infections and infections by other high-risk HPV, in 30% of infections by undetermined HPV types and was negative in tumors caused by low-risk HPV. The percentage of tumors with basaloid or warty histology ranged from 70% in HPV33-positive tumors to <40% in HPV 18 or HPV45-positive tumors.
Histological characteristics of unquestionable HPVassociated and -independent tumors
HPV typing and histological classification
HPV mRNA detection
Adequate material for mRNA detection was available in 402 out of 441 (91.1%) HPV DNA-positive tumors. HPV mRNA In the subset of 18 HPV DNA-negative tumors tested for mRNA, eight tumors were HPV DNA2/p161 and 10 HPV DNA2/p162. Two out of eight (25%) HPV DNA2/p161 tumors were positive for HPV mRNA, whereas none of the 10 unquestionably HPV-independent tumors (HPV DNA2/ p162) were positive for HPV mRNA.
Discussion
Our study, which includes a large number of VSCCs, confirms previous results obtained by our group, 14, 16 showing that there is significant overlap between the histological types of VSCC and the association with HPV. Indeed, 36.5% of the unquestionably HPV-associated VSCCs were of the conventional keratinizing type, the histological type considered as characteristic of the HPV-independent pathway of VSCC. 3, 5, 14, 16, [38] [39] [40] However, a small, albeit significant, number of indisputably HPVindependent VSCCs showed basaloid or warty features (5.2%), HPV DNA2 and p162 the histological types usually considered as associated with HPV-driven VSCCs. 3, 5, 14, 16, 38, 41, 42 This high prevalence of HPV infection among keratinizing VSCCs has also been observed by other authors, who have found percentages similar to or higher than those observed in our study. 2, 14, 20, [43] [44] [45] Thus, the present results confirm the limited reliability of the current WHO classification of VSCCs in terms of HPV attribution. 5, 14, 41 The poor correlation observed between histological typing and HPV infection may be related, in part, by a certain degree of subjectivity in subclassifying the tumors observed in our study as previously referred by some authors. 14, 41 These difficulties are particularly challenging in the diagnosis of nonkeratinizing carcinoma and to a lesser extent, warty carcinomas. 14 In addition, the presence of keratinization in basaloid carcinomas can hinder the differential diagnosis with poorly differentiated keratinizing squamous cell carcinomas. Moreover, mixed basaloid-keratinizing squamous carcinomas posing serious diagnostic problems have been described. 17 The marked overlap observed in all the histological features evaluated in our study clearly highlights the absence of specific criteria that allow classifying a tumor as HPV-associated orindependent. Indeed, although many of the histological findings evaluated in our study showed significant differences between the two groups, all the characteristics were found in a large proportion of HPV-associated and -independent tumors. A particularly unspecific feature is the presence of koilocytoticlike changes, which were observed in 11.6% of the HPVindependent VSCCs. Moreover, a marked interobserver variability in the separation between pseudokoilocytotic and true koilocytotic changes has been reported. 14, 46 These findings further stress the poor validity of morphology alone to distinguish the two etio-pathogenic types of VSCC. 5, 14, [20] [21] [22] 25, 41, 47 Our study shows that 10.5% of the tumors had nonconclusive features in terms of HPV attribution assessed by HPV DNA and p16. The most frequent group (HPV DNA2/ p161) was comparable to the unquestionably HPV-associated group in terms of age and histological typing. These findings indicate that these cases may represent false-negative results of HPV DNA detection. In these cases the poor tissue quality could have contributed to the false-negative HPV DNA result. 2 In contrast, the other non-conclusive group (HPV DNA1/ p162) is more heterogeneous. It includes the unusual VSCCs (12 cases) harboring only a low-risk HPV, which have been shown to be negative for p16 IHC. 48 Some of the cases represented p16 negativity in truly HPV-positive tumors, as shown by the identification of 16 tumors positive not only for HPV DNA but also for HPV mRNA. However, it is likely that some of these cases are false-positive HPV DNA cases. This group was more similar to the indisputably HPV-independent group in terms of histological characteristics and age range. Moreover, the infrequent presence of mRNA in these tumors (32.0% vs. 94.9% in the HPV DNA1/p161 group) after excluding all cases not tested for mRNA HPV, as the test was not designed for low-risk and undetermined HPV types, is also in keeping with this hypothesis. As the whole FFPE block was tested for HPV detection without performing tumor microdissection, we cannot exclude the possibility of contamination from the adjacent embedded tissue not related to the tumor. Thus, our results suggest that HPV DNA detection alone could misclassify up to 10% of cases, whereas despite not being perfect, p16 immunohistochemistry could be a more reliable tool, offering even better sensitivity and specificity. p53 IHC was positive in only 5% of the unquestionably HPV-associated tumors and in 66.7% of the unquestionably HPV-independent tumors. These results are in keeping with previous reports showing that p53 abnormalities are infrequent in HPV-associated tumors and present in about two-thirds of HPV-independent tumors. 14, 49 Interestingly, the percentage of p53 positivity in HPV DNA2/ p161 tumors was comparable to the unquestionably HPVassociated neoplasms whereas HPV DNA1/p162 tumors were more similar to the indisputably HPV-independent carcinomas. These results add further evidence indicating that DNA2/ p161 tumors probably represent false-negative results of HPV DNA detection, whereas many of the HPV DNA1/p162 tumors are false-positive HPV DNA cases.
In situ hybridization assays that can detect HPV E6/E7 mRNA in FFPE tissue and allow visualization of the transcripts within tumor cells have recently become available. Although the value of these assays needs to be confirmed, they might help in the identification of HR-HPV-associated neoplasia in the vulva, the anus and the head and neck region. 50 The main strength of our study is that it includes a very high number of VSCC, and in all the cases, a detailed histological review and thorough molecular analysis including HPV DNA, mRNA and p16 were performed. The correlation of all the data allowed the study to obtain more accurate evidence of HPV involvement in the large series of tumors. 28 The study has also some limitations. Only one FFPE block per case was available for review. This may, to some extent, have influenced the histological type distribution and, particularly, may have resulted in a relatively high percentage of non-keratinizing tumors, as keratin pearl formation may have been focal or absent in the area sampled. In addition, although HPV DNA detection in our study has fulfilled strict quality controls, the different tissue processing techniques performed in a large variety of contributing laboratories could have had an impact on our results. However, the high number of cases analyzed and the strict quality controls used for p16 staining and HPV DNA and RNA detection have probably minimized this effect.
Finally, the complete absence of clinical and follow-up data prevents obtaining any conclusions on the prognostic implications of HPV status. Although there are some discordant results on the prognostic significance of HPV in VSCC, 8, 20 recent evidence indicates a strong association between positive p16 IHC and lower FIGO stage and negative lymph node metastasis, 7 and that the presence of HPV DNA or positive p16 IHC is an independent prognostic factor. 6 In conclusion, our study performed in a large number of cases of vulvar carcinomas confirms that histological criteria do not allow differentiation between HPV-associated andindependent VSCC. Although not perfect, p16 is a good surrogate marker that could even outperform the HPV DNA detection technique. Venezuela: Victoria Garc ıa Barriola, Mirian Naranjo de G omez, Adayza Figueredo, Janira Navarro (Universidad Central de Venezuela).
